Clinical Trial Update: Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study of retreatment with daratumumab in patients with multiple myeloma who had prior daratumumab expo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2023-12-19